KIRK STEPHENS: Open Payments
NPI 1992221980 · MIDVALE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 65 payments from 14 companies in 2025. Trend: 2023 $899 · 2024 $1,402 · 2025 $1,153
Food & beverage: $1,153
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 18 | $347 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $169 |
| Arcutis Biotherapeutics, Inc. | 11 | $137 |
| UCB, Inc. | 4 | $106 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| Amgen Inc. | 1 | $92 |
| Janssen Biotech, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $34 |
| Organon LLC | 3 | $29 |
| GENZYME CORPORATION | 1 | $24 |
Products named: NEMLUVIO, Zoryve, Bimzelx, Winlevi, OTEZLA, COSENTYX, ILUMYA, AKLIEF.
Industry payments across UT — which companies pay providers there.
